Lion Biotechnologies CEO Maria Fardis' 2018 pay jumps 1,005% to $9.4M
Lion Biotechnologies reports 2018 executive compensation
By ExecPay News
Published: April 29, 2019
Lion Biotechnologies reported fiscal year 2018 executive compensation information on April 29, 2019.
In 2018, three executives at Lion Biotechnologies received on average a compensation package of $3.5M, a 228% increase compared to previous year.
Maria Fardis, Chief Executive Officer, received $9.4M in total, which increased by 1,005% compared to 2017. 88% of Fardis' compensation, or $8.3M, was in option awards. Fardis also received $510K in non-equity incentive plan and $600K in salary.
For fiscal year 2018, the median employee pay was $312,125 at Lion Biotechnologies. Therefore, the ratio of Maria Fardis' pay to the median employee pay was 30 to one.
Timothy E. Morris, Chief Financial Officer, received a compensation package of $603K, which decreased by 60% compared to previous year. 75% of the compensation package, or $450K, was in salary.
Frederick G. Vogt, General Counsel, earned $503K in 2018, a 41% decrease compared to previous year.